Colorectal Unit, General and Digestive Surgery Department, Hospital Universitario Son Espases, Palma, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
Tech Coloproctol. 2024 Aug 20;28(1):111. doi: 10.1007/s10151-024-02974-8.
This study presents a laparoscopic surgical protocol for right hemicolectomy and D3 lymphadenectomy (R-D3L) in right colon cancer and reports the oncological outcomes based on a prospective series.
The study comprises two phases. In the first phase, a dynamic demonstration of the R-D3L surgical protocol is provided through textual explanation, illustrations, and edited surgical videos. The protocol emphasizes technical steps such as dissection of the embryological plane of the right mesocolon, high tie of ileocolic vessels, surgical trunk of Gillot dissection, and high tie of superior right colic vein (SRCV). In the second phase, a prospective observational study was conducted involving patients undergoing R-D3L surgery with this protocol between July 2015 and July 2021. Demographic, perioperative, and postoperative variables are analyzed, along with anatomopathological variables and oncological outcomes.
A total of 33 patients were analyzed. Median operative time was 202 min. Perioperative bleeding occurred in 6%. Postoperative complications were mild (Clavien-Dindo III in 2%). Postoperative ileus was observed in 15%. No anastomotic dehiscence was reported. The median postoperative stay was 7 days. The median number of resected lymph nodes was 26, with 27% having positive nodes and 70% were classified as stage T3 or T4. After a median follow-up of 45 months, local recurrence, distant recurrence, and carcinomatosis rates were 0%. Mortality rate from other causes was 9%.
The surgical protocol shown in the present study could help in the implementation of this technique in those units that consider it appropriate.
本研究提出了一种腹腔镜右半结肠癌根治术和 D3 淋巴结清扫术(R-D3L)的手术方案,并基于前瞻性系列研究报告了其肿瘤学结果。
该研究包括两个阶段。第一阶段通过文字说明、插图和编辑手术视频对 R-D3L 手术方案进行了动态演示。该方案强调了解剖胚胎层面的右结肠系膜、结扎回结肠血管、Gillot 解剖干、结扎右结肠上静脉(SRCV)等技术步骤。第二阶段,对 2015 年 7 月至 2021 年 7 月期间采用该方案行 R-D3L 手术的患者进行了前瞻性观察性研究。分析了患者的人口统计学、围手术期和术后变量,以及解剖病理学变量和肿瘤学结果。
共分析了 33 例患者。中位手术时间为 202 分钟。术中出血量为 6%。术后并发症为轻度(Clavien-Dindo Ⅲ级 2%)。术后发生肠梗阻 15%。无吻合口裂开。术后中位住院时间为 7 天。中位淋巴结清扫数目为 26 枚,阳性淋巴结占 27%,T3 或 T4 期占 70%。中位随访 45 个月后,局部复发、远处转移和癌播散率均为 0%。因其他原因导致的死亡率为 9%。
本研究中展示的手术方案可以帮助那些认为合适的单位实施该技术。